Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-17T03:22:54.921Z Has data issue: false hasContentIssue false
  • English
  • Français

Assessing Impairment of Executive Function and Psychomotor Speed in Premanifest and Manifest Huntington’s Disease Gene-expansion Carriers

Published online by Cambridge University Press:  08 April 2015

Ida Unmack Larsen ,
Tua Vinther-Jensen ,
Anders Gade ,
Jørgen Erik Nielsen  and
Asmus Vogel
Ida Unmack Larsen*
Affiliation:
Neurogenetics Clinic, Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Department of Psychology, University of Copenhagen, Copenhagen, Denmark
Tua Vinther-Jensen
Affiliation:
Neurogenetics Clinic, Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Department of Cellular and Molecular Medicine, Section of Neurogenetics, University of Copenhagen, Copenhagen, Denmark
Anders Gade
Affiliation:
Department of Psychology, University of Copenhagen, Copenhagen, Denmark
Jørgen Erik Nielsen
Affiliation:
Neurogenetics Clinic, Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Department of Cellular and Molecular Medicine, Section of Neurogenetics, University of Copenhagen, Copenhagen, Denmark
Asmus Vogel
Affiliation:
Neurogenetics Clinic, Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
*
Correspondence and reprint requests to: Ida Unmack Larsen, Danish Dementia Research Centre, dep. 6991, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Ø. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Executive functions (EF) and psychomotor speed (PMS) has been widely studied in Huntington’s disease (HD). Most studies have focused on finding markers of disease progression by comparing group means at different disease stages. Our aim was to investigate performances on nine measures of EF and PMS in a group of premanifest and manifest HD-gene expansion carriers and to investigate which measures were most sensitive for assessment of individual patients by analyzing frequencies of impaired performances relative to healthy controls. We recruited HD gene-expansion carriers, 48 manifest and 50 premanifest and as controls 39 healthy gene-expansion negative individuals. All participants underwent neurological examination and neuropsychological testing with nine cognitive measures. The frequency of impairment was investigated using cutoff scores. In group comparisons the manifest HD gene-expansion carriers scored significantly worse than controls on all tests and in classification of individual scores the majority of scores were classified as probably impaired (10th percentile) or impaired (5th percentile) with Symbol Digit Modalities Test (SDMT) being the most frequently impaired. Group comparisons of premanifest HD gene-expansion carriers and healthy controls showed significant differences on SDMT and Alternating fluency tests. Nevertheless the frequencies of probably impaired and impaired scores on individual tests were markedly higher for Alternating and Lexical fluency tests than for SDMT. We found distinct group differences in frequency of impairment on measures of EF and PMS in manifest and premanifest HD gene-expansion carriers. Our results indicate to what degree these measures can be expected to be clinically impaired. (JINS, 2015, 21, 1–10)

Keywords

NeuropsychologyAssessmentCognitionExecutive testsNeurodegenerative diseaseVerbal fluency
Type
Research Articles
Information
Journal of the International Neuropsychological Society , Volume 21 , Issue 3 , March 2015 , pp. 193 - 202
Copyright
Copyright © The International Neuropsychological Society 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

The Huntington’s Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971–983.Google Scholar
Huntington Study Group (1996). Unified Huntington’s Disease Rating Scale: Reliability and consistency. Movement Disorders, 11, 136–142.Google Scholar
Alexander, G.E., DeLong, M.R., & Strick, P.L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357–381.Google Scholar
Brandt, J., Inscore, A.B., Ward, J., Shpritz, B., Rosenblatt, A., Margolis, R.L., & Ross, C.A. (2008). Neuropsychological deficits in Huntington’s disease gene carriers and correlates of early “conversion”. Journal of Neuropsychiatry and Clinical Neuroscience, 20, 466–472. doi:10.1176/appi.neuropsych.20.4.466 CrossRefGoogle ScholarPubMed
Burgess, P.W., Alderman, N., Forbes, C., Costello, A., Coates, L.M., Dawson, D.R., … Channon, S. (2006). The case for the development and use of “ecologically valid” measures of executive function in experimental and clinical neuropsychology. Journal of the International Neuropsychological Society, 12, 194–209.CrossRefGoogle ScholarPubMed
Burgess, P.W., & Shallice, T. (1997). The Hayling and Brixton tests. London: Pearson Assessment.Google Scholar
Costa, A., Bagoj, E., Monaco, M., Zabberoni, S., De Rosa, S., Papantonio, A.M., … Carlesimo, G.A. (2014). Standardization and normative data obtained in the Italian population for a new verbal fluency instrument, the phonemic/semantic alternate fluency test. Neurological Sciences, 35, 365–372. doi:10.1007/s10072-013-1520-8 Google Scholar
Crawford, J.R., Parker, D.M., & Besson, J.A. (1988). Estimation of premorbid intelligence in organic conditions. The British Journal of Psychiatry, 153, 178–181.Google Scholar
Duff, K., Paulsen, J., Mills, J., Beglinger, L.J., Moser, D.J., Smith, M.M., … Harrington, D.L. (2010). Mild cognitive impairment in prediagnosed Huntington disease. Neurology, 75, 500–507.Google Scholar
Dumas, E.M., van den Bogaard, S.J., Middelkoop, H.A., & Roos, R.A. (2013). A review of cognition in Huntington’s disease. Frontiers in Bioscience (Scholar Edition), 5, 1–18.Google Scholar
Duncan, J., Burgess, P., & Emslie, H. (1995). Fluid intelligence after frontal lobe lesions. Neuropsychologia, 33, 261–268.CrossRefGoogle ScholarPubMed
Field, A. (2013). Discovering statistics using IBM SPSS statistics. Thousand Oaks, CA: Sage.Google Scholar
Glascher, J., Adolphs, R., Damasio, H., Bechara, A., Rudrauf, D., Calamia, M., … Tranel, D. (2012). Lesion mapping of cognitive control and value-based decision making in the prefrontal cortex. Proceedings of the National Academy of Science United States of America, 109, 14681–14686.CrossRefGoogle ScholarPubMed
Harrington, D.L., Smith, M.M., Zhang, Y., Carlozzi, N.E., & Paulsen, J.S. (2012). Cognitive domains that predict time to diagnosis in prodromal Huntington disease. Journal of Neurology, Neurosurgery, and Psychiatry, 83, 612–619. doi:10.1136/jnnp-2011-301732 Google Scholar
Holl, A.K., Wilkinson, L., Tabrizi, S.J., Painold, A., & Jahanshahi, M. (2013). Selective executive dysfunction but intact risky decision-making in early Huntington’s disease. Movement Disorders, 28, 1104–1109. doi:10.1002/mds.25388 CrossRefGoogle ScholarPubMed
Jurado, M.B., & Rosselli, M. (2007). The elusive nature of executive functions: A review of our current understanding. Neuropsychology Review, 17, 213–233.Google Scholar
Larsson, M.U., Almkvist, O., Luszcz, M.A., & Wahlin, T.B. (2008). Phonemic fluency deficits in asymptomatic gene carriers for Huntington’s disease. Neuropsychology, 22, 596–605. doi:10.1037/0894-4105.22.5.596 Google Scholar
Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., Vandenbussche, E., & Dom, R. (2002). Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington’s disease mutation after 1 year. Acta Neurologica Scandinavica, 106, 131–141.Google Scholar
Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., Vandenbussche, E., & Dom, R. (2004). Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study. Journal of Neurology, 251, 935–942.Google Scholar
Lezak, M.D. (2004). Neuropsychological assessment. Oxford: Oxford University Press.Google Scholar
Montoya, A., Price, B.H., Menear, M., & Lepage, M. (2006). Brain imaging and cognitive dysfunctions in Huntington’s disease. Journal of Psychiatry & Neuroscience, 31, 21–29.Google ScholarPubMed
Mortensen, E.L., & Gade, A. (1993). On the relation between demographic variables and neuropsychological test performance. Scandinavian Journal of Psychology, 34, 305–317.Google Scholar
Nasreddine, Z.S., Phillips, N.A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., … Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695–699.Google Scholar
Nelson, H.E., & O’Connell, A. (1978). Dementia: The estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex, 14, 234–244.Google Scholar
Nicoll, D.R., Pirogovsky, E., Woods, S.P., Holden, H.M., Filoteo, J.V., Gluhm, S., … Gilbert, P.E. (2014). “Forgetting to remember” in Huntington’s disease: A study of laboratory, semi-naturalistic, and self-perceptions of prospective memory. Journal of the International Neuropsychological Society, 20, 192–199. doi:10.1017/S1355617713001355 Google Scholar
O’Carroll, R. (2014). The Assessment of premorbid ability: A critical review. Neurocase, 1, 83–89.Google Scholar
Paulsen, J.S. (2011). Cognitive impairment in Huntington disease: Diagnosis and treatment. Current Neurology and Neuroscience Reports, 11, 474–483. doi:10.1007/s11910-011-0215-x Google Scholar
Paulsen, J.S., Smith, M.M., & Long, J.D. (2013). Cognitive decline in prodromal Huntington Disease: Implications for clinical trials. Journal of Neurology, Neurosurgery, and Psychiatry, 84, 1233–1239. doi:10.1136/jnnp-2013-305114 Google Scholar
Peinemann, A., Schuller, S., Pohl, C., Jahn, T., Weindl, A., & Kassubek, J. (2005). Executive dysfunction in early stages of Huntington’s disease is associated with striatal and insular atrophy: A neuropsychological and voxel-based morphometric study. Journal of the Neurological Sciences, 239, 11–19.Google Scholar
Porter, R.J., Bourke, C., & Gallagher, P. (2007). Neuropsychological impairment in major depression: Its nature, origin and clinical significance. Australian and New Zealand Journal of Psychiatry, 41, 115–128.Google Scholar
Ready, R.E., Mathews, M., Leserman, A., & Paulsen, J.S. (2008). Patient and caregiver quality of life in Huntington’s disease. Movement Disorders, 23, 721–726. doi:10.1002/mds.21920 Google Scholar
Reitan, R.M. (1955). The relation of the trail making test to organic brain damage. Journal of Consulting Psychology, 19, 393–394.Google Scholar
Robinson, G., Shallice, T., Bozzali, M., & Cipolotti, L. (2012). The differing roles of the frontal cortex in fluency tests. Brain, 135, 2202–2214.Google Scholar
Roos, R.A. (2010). Huntington’s disease: A clinical review. Orphanet Journal of Rare Diseases, 5, 40. doi:10.1186/1750-1172-5-40 Google Scholar
Royall, D.R., Lauterbach, E.C., Cummings, J.L., Reeve, A., Rummans, T.A., Kaufer, D.I., … Coffey, C.E. (2002). Executive control function: A review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. Journal of Neuropsychiatry and Clinical Neuroscience, 14, 377–405.CrossRefGoogle Scholar
Smith, A. (1982). Symbol digit modalities test: Manual. Los Angeles: Western Psychological Services.Google Scholar
Snowden, J., Craufurd, D., Griffiths, H., Thompson, J., & Neary, D. (2001). Longitudinal evaluation of cognitive disorder in Huntington’s disease. Journal of the International Neuropsychological Society, 7, 33–44.Google Scholar
Starkstein, S.E., Brandt, J., Folstein, S., Strauss, M., Berthier, M.L., Pearlson, G.D., … Folstein, M. (1988). Neuropsychological and neuroradiological correlates in Huntington’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 51, 1259–1263.Google Scholar
Stout, J.C., Paulsen, J.S., Queller, S., Solomon, A.C., Whitlock, K.B., Campbell, J.C., & Aylward, E.H. (2011). Neurocognitive signs in prodromal Huntington disease. Neuropsychology, 25, 1–14. doi:10.1016/S1474-4422(11)70263-0 Google Scholar
Stout, J.C., Queller, S., Baker, K.N., Cowlishaw, S., Sampaio, C., Fitzer-Attas, C., … Borowsky, B. (2014). HD-CAB: A cognitive assessment battery for clinical trials in Huntington’s disease 1,2,3. Movement Disorders, 29, 1281–1288.Google Scholar
Stroop, J.R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643–662.Google Scholar
Stuss, D.T., & Alexander, M.P. (2007). Is there a dysexecutive syndrome? Philosophical Transactions of the Royal Society of London. Series B. Biological Sciences, 362, 901–915.Google Scholar
Tabrizi, S.J., Reilmann, R., Roos, R.A., Durr, A., Leavitt, B., Owen, G., … Langbehn, D.R. (2012). Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: Analysis of 24 month observational data. The Lancet Neurology, 11, 42–53.Google Scholar
Tabrizi, S.J., Scahill, R.I., Durr, A., Roos, R.A., Leavitt, B.R., Jones, R., … Stout, J.C. (2011). Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: The 12-month longitudinal analysis. The Lancet Neurology, 10, 31–42. doi:10.1016/S1474-4422(10)70276-3 CrossRefGoogle Scholar
Testa, R., Bennett, P., & Ponsford, J. (2012). Factor analysis of nineteen executive function tests in a healthy adult population. Archives of Clinical Neuropsychology, 27, 213–224.Google Scholar
Unschuld, P.G., Liu, X., Shanahan, M., Margolis, R.L., Bassett, S.S., Brandt, J., … Ross, C.A. (2013). Prefrontal executive function associated coupling relates to Huntington’s disease stage. Cortex, 49, 2661–2673.Google Scholar
Veiel, H.O. (1997). A preliminary profile of neuropsychological deficits associated with major depression. Journal of Clinical and Experimental Neuropsychology, 19, 587–603.Google Scholar
Vinther-Jensen, T., Larsen, I.U., Hjermind, L.E., Budtz-Jorgensen, E., Nielsen, T.T., Norremolle, A., … Vogel, A. (2014). A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington’s disease. Orphanet Journal of Rare Diseases, 9, 114. doi:10.1186/s13023-014-0114-8 CrossRefGoogle ScholarPubMed
Wilson, B.A., Alderman, N., Burgess, P.W., Emslie, H., & Evans, J.J. (1996). Behavioural assessment of the dysexecutive syndrome: Manual. Bury St Edmunds, England: Thames Valley Test Company.Google Scholar
Zec, R.F., Landreth, E.S., Fritz, S., Grames, E., Hasara, A., Frazier, W., … Manyam, B. (1999). A comparison of phonemic, semantic and alternating word fluency in Parkinson’s disease. Archives of Clinical Neuropsychology, 14, 255–264.Google Scholar
Zhang, Y., Long, J.D., Mills, J.A., Warner, J.H., Lu, W., & Paulsen, J.S. (2011). Indexing disease progression at study entry with individuals at-risk for Huntington disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 156B, 751–763. doi:10.1002/ajmg.b.31232 Google Scholar